SALMAN, A. Et Al. 2020. Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: a retrospective cohort study.. The Journal of dermatological treatment , vol.31, no.2 , 204-209.

SALMAN, A., Ergun, T., & Maria Gimenez-Arnau, A., (2020). Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: a retrospective cohort study.. The Journal of dermatological treatment , vol.31, no.2, 204-209.

SALMAN, ANDAÇ, SAFİYE ATLAS TÜLİN ERGUN, And Ana Maria Gimenez-Arnau. "Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: a retrospective cohort study.," The Journal of dermatological treatment , vol.31, no.2, 204-209, 2020

SALMAN, ANDAÇ Et Al. "Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: a retrospective cohort study.." The Journal of dermatological treatment , vol.31, no.2, pp.204-209, 2020

SALMAN, A. Ergun, T. And Maria Gimenez-Arnau, A. (2020) . "Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: a retrospective cohort study.." The Journal of dermatological treatment , vol.31, no.2, pp.204-209.

@article{article, author={ANDAÇ SALMAN Et Al. }, title={Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: a retrospective cohort study.}, journal={The Journal of dermatological treatment}, year=2020, pages={204-209} }